Results 111 to 120 of about 470,683 (177)

Cardiolipin deficiency disrupts CoQ redox state and induces steatohepatitis

open access: yes
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive disorder marked by lipid accumulation, leading to steatohepatitis (MASH). A key feature of the transition to MASH involves oxidative stress resulting from defects in mitochondrial oxidative phosphorylation (OXPHOS). Here, we show that pathological alterations in the lipid
Brothwell, Marisa J.   +34 more
openaire   +2 more sources

Pathological and therapeutic mechanisms in CoQ deficiency: the role of the proteins involved in the Q-Junction

open access: yes, 2023
Mitochondria are present in most cell types. Structurally, mitochondria have two phospholipid membranes that define four biochemically distinct compartments: the outer membrane, the intermembrane space, the inner membrane and the mitochondrial matrix.
openaire   +1 more source

Cardiolipin deficiency disrupts CoQ-complex III interface in steatohepatitis

open access: yes
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive disorder marked by lipid accumulation, leading to steatohepatitis (MASH). A key feature of the transition to MASH involves oxidative stress resulting from defects in mitochondrial oxidative phosphorylation (OXPHOS).
Brothwell, Marisa   +34 more
openaire   +1 more source

Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis. [PDF]

open access: yesElife
Brothwell MJ   +34 more
europepmc   +1 more source

Preclinical and first-in-human evidence of 4-hydroxybenzoic acid for mitochondrial COQ2 deficiency. [PDF]

open access: yesBrain
Distelmaier F   +14 more
europepmc   +1 more source

Mitochondrial NAD kinase Pos5 is required for CoQ biosynthesis in yeasts. [PDF]

open access: yesPLoS One
Nishihara S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy